Hannah Hoag. Show Affiliations »
Abstract
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedClinical Trials as Topic/trendsDrug ApprovalDrug Industry/trendsHumansLeukoencephalopathy, Progressive Multifocal/chemically inducedNatalizumabRisk AssessmentUnited States
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedNatalizumab
Year: 2008 PMID: 18846062 DOI: 10.1038/nbt1008-1061
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908